DLX5 and Guillain-Barre syndrome: DLX5 has been shown to be involved in the development of the olfactory system [36], and ZIKV has recently been associated with olfactory disorders in mice [37] as well as reduced olfactory function in patients with ZIKV-induced Guillain-Barré syndrome [38].